Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
10.88 USD | +0.32% | +0.98% | +139.27% |
06-20 | Mizuho Securities Raises Price Target on ADMA Biologics to $14 From $12, Maintains Buy Rating | MT |
06-17 | Adma Biologics Insider Sold Shares Worth $2,548,580, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+139.27% | 2.51B | |
+2.97% | 94.74B | |
-4.08% | 37.28B | |
-11.87% | 32.68B | |
+74.97% | 27.72B | |
-13.38% | 16.19B | |
-2.42% | 13.88B | |
-11.67% | 11.58B | |
+190.36% | 10.92B | |
-52.61% | 9.54B |
- Stock Market
- Equities
- ADMA Stock
- News ADMA Biologics, Inc.
- Adma Biologics Insider Sold Shares Worth $2,548,580, According to a Recent SEC Filing